Eurasian Journal of Biosciences

An exploration of the relationship between interleukin 37, 8-ohdg and a number of anthropometric measurements in iraqi rheumatoid arthritis patients
  • Article Type: Research Article
  • Eurasian Journal of Biosciences, 2020 - Volume 14 Issue 1, pp. 71-79
  • Published Online: 28 Feb 2020
  • Open Access Full Text (PDF)


Background: Anti-inflammatory intermediaries like interleukin-37 (IL-37) have a central function in the disease regulation of rheumatoid arthritis (RA). This study was designed to explore the relationship between IL-37, 8-hydroxydeoxyguanosine (8-OHDG) and certain anthropometric measurements in RA patients, and to investigate whether there are any correlations between IL-37 and 8-OHDG. Materials and Methods: The study comprised 60 patients with RA and 24 age- and sex-matched healthy control subjects (HCs). IL-37 and 8-OHDG serum concentrations were estimated by ELISA. The width of waist (W.W), hip (W.H), thorax (W.T) and neck (W.N) were calculated, along with body mass index (BMI) for all subjects. Results: IL-37 and 8-OHDG serum concentrations were significantly greater in patients with RA. Nevertheless, RA patients showed lower levels of high-density lipoprotein (HDL) and hemoglobin (Hb). Elevated serum concentrations of IL-37 were found to be positively associated with waist to hip ratio (W/H), waist to thoracic ratio (W/T), waist to neck ratio (W/N), ESR and Hb, while raised serum concentrations of 8-OHDG were positively related with W/H, W/T, SBP, DBP, creatinine and total cholesterol (TC). IL-37 exhibited the highest ROC curve value in comparison to other studied markers. Conclusion: Both anti-inflammatory cytokine (IL-37) and the marker of DNA impairment (8-OHDG) form part of RA’s pathogenesis. IL-37 and 8-OHDG may be used as possible biomarkers of active RA.


  • Akdis M, Burgler S, Crameri R, et al. (2011) Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 127: 701-721.
  • Alberti KGM, Zimmet P, Shaw J. (2005) The metabolic syndrome-a new worldwide definition. Lancet. 366: 1059-1062.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315-324.
  • Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum, 59: 1690-1697.
  • Biswas S, Sharma S, Saroha A, et al. (2013) Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach. PLoS One, 8: e56246.
  • Chong YC, Heppner GH, Paul LA, Fulton AM. (1989) Macrophage-mediated induction of DNA strand breaks in target tumour cells. Cancer Res. 49: 6652-6657.
  • Dalton M, Cameron AJ, Zimmet PZ, et al. (2003) Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 254: 555-563.
  • Emerit I, Michelson AM. (1980) Chromosome instability in human and murine autoimmune disease: anticlastogenic effect of superoxide dismutase. Acta Physiol Scand, suppl 492: 59-65.
  • Fawzy RM, Ganeb SS, Said EA, et al. (2016) Serum level of interleukin-37 and expression of its mRNA in ankylosing spondylitis patients: possible role in osteoporosis. Egypt J Immunol, 23: 19-29.
  • Frijhoff J, Winyard PG, Zarkovic N. (2015) Clinical Relevance of Biomarkers of Oxidative Stress. Antioxidants & Redox Signaling, 23(14): 1144-1170.
  • Huang QL, Zhou FJ, Wu CB, et al. (2017) Circulating biomarkers for predicting infliximab response in rheumatoid arthritis: A systematic bioinformatics analysis. Med Sci Monit, 23: 1849-1855
  • Janssen I, Katzmarzyk PT, Ross R. (2004) Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 79: 379-384.
  • Kennedy A, Fearon U, Veale DJ, Godson C. (2011) Macrophages in Synovial Inflammation. Frontiers in Immunology, 2(52): 1-9.
  • Li C, Engstrom G, Hedblad B, Calling S, Berglund G, Janzon L. (2006) Sex differences in the relationships between BMI, WHR and incidence of cardiovascular disease: a population-based cohort study. Int J Obes. 30: 1775-1781.
  • Liu Y, Shu Q, Gao L, et al. (2010) Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin Immunol, 137: 288-295.
  • Lu B, Hiraki LT, Sparks JA, et al. (2014) being overweight or obese and risk of development rheumatoid arthritis among women: a prospective cohort studies. Ann. Rheum Dis. 73: 843-855.
  • Lushchak VI. (2014) Free radicals, reactive oxygen species, oxidative stress and its classification. Chem. Biol. Interact. 224: 164-175.
  • McInnes IB, Schett G. (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol, 7: 429-442.
  • McNamee EN, Masterson JC, Jedlicka P, et al. (2011) Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci. U S A, 108: 16711-16716.
  • Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. (2014) Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Sig. 20(7): 1126-1167.
  • Moretti S, Bozza S, Oikonomou V, et al. (2014) IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis. PLoS Pathog. 10(11): e1004462
  • Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. (2004) Splanchnic lipolysis in human obesity. J Clin Invest. 113(11): 1582-1588.
  • Nold MF, Nold-Petry CA, Lo C, et al. (2013) 187: Interleukin 37 employs the IL‐1 family inhibitory receptor SIGIRR and the alpha chain of the IL‐18 receptor to suppress innate immunity. Cytokine. 63(3): 287.
  • Nold MF, Nold-Petry CA, Zepp JA, et al. (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol, 11: 1014-1022.
  • Pasceri VA. (1999) A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation, 100: 2124-2126.
  • Pilger A, Rüdiger Ru, et al. (2006) HW. 8-Hydroxy-2’-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures. Int Arch Occup Environ Health. 80(1):1-15.
  • Seven A, Uuzel SG, Aslan M, Hamuryudan V. (2008) Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clinical Biochemistry, 41: 538-543.
  • Song L, Qiu F, Fan Y, et al. (2013) Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. J Clin Immunol, 33: 111-117.
  • Song L, Wang Y, Sui Y, Sun J, Li D, Li G, Liu J, Li T , Shu Q. (2018) High Interleukin-37 (IL-37) Expression and Increased Mucin-Domain Containing-3 (TIM-3) on Peripheral T Cells in Patients with Rheumatoid Arthritis. Med Sci Monit, 24: 5660-5667
  • Tetè S, Tripodi D, Rosati M, et al. (2012) IL-37 (iL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation. Int J Immunopathol Pharmacol 25(1):31-38.
  • Valavanidis A, Vlachogianni T, Fiotakis C. (2009) 8-Hydroxy-2’-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 27(2): 120-139.
  • Versini M, Jeandel PY, Rosenthal E, et al. (2014) obesity in autoimmune disease: not a passive bystander. Autoimmune Rev. 13: 981-1000.
  • Wei M, Duan D. (2016) Efficacy and safety of monoclonal antibodies targeting interleukin‐17 pathway for inflammatory arthritis: a metaanalysis of randomized controlled clinical trials. Drug Des Devel Ther. 10: 2771‐2777.
  • Weitberg AB, Weitzman SA, Destrempes M, Latt SA, Stossel TP. (1983) Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells. N Engl Med 308: 26-29.
  • World Health Organisation. (2000) Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. World Health Organ Tech Rep Ser. 894:i-xii:1-253.
  • Wu GC, Li HM, Wang JB, et al. (2016) Elevated plasma interleukin-37 levels in systemic lupus erythematosus patients. Lupus, 25: 1377-1380.
  • Xu WD, Zhao Y, Liu Y. (2015) Insights into IL-37, the role in autoimmune diseases. Autoimmune Rev, 14: 1170-1175.
  • Yang L, Zhang J, Tao J, et al. (2015) Elevated serum levels of interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis. APMIS, 123: 1025-1031.
  • Ye L, Huang Z. (2015) IL-37 restrains autoimmune diseases. Oncotarget, 6: 21775-21776.
  • Yuan ZC, Wang JM, Huang AF, Su LS, Li SJ, Xu WD. (2019) Elevated expression of interleukin‐37 in patients with rheumatoid arthritis. Int J Rheum Dis. 22(6):1123-1129.
  • Yusuf S, Hawken S, Ounpuu S, et al. (2005) Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366: 1640-1649.


This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.